You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK — ProciseDx said on Tuesday that it has received CE marking for its Procise FCP point-of-care test for inflammatory bowel disease.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.